JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,620
-290 (-2.25%)
Apr 2, 2026, 3:30 PM KST

JW Lifescience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
199,906198,977168,472199,286188,137214,461
Market Cap Growth
23.07%18.11%-15.46%5.93%-12.27%-34.73%
Enterprise Value
239,989222,030157,490227,270221,603261,011
Last Close Price
12910.0012315.8010427.6911792.5310711.1111730.97
PE Ratio
6.996.963.837.0812.5816.61
Forward PE
-13.9213.9213.9213.9213.92
PS Ratio
0.780.770.760.961.001.26
PB Ratio
0.910.900.841.251.341.63
P/TBV Ratio
1.391.391.371.281.381.69
P/FCF Ratio
7.147.114.176.7731.1019.17
P/OCF Ratio
4.934.913.325.3013.327.11
EV/Sales Ratio
0.930.860.711.101.171.54
EV/EBITDA Ratio
4.674.323.054.905.276.27
EV/EBIT Ratio
7.226.684.397.368.189.19
EV/FCF Ratio
8.587.943.907.7336.6323.33
Debt / Equity Ratio
0.230.230.350.290.480.35
Debt / EBITDA Ratio
0.980.981.341.001.601.12
Debt / FCF Ratio
1.811.811.721.5711.114.16
Net Debt / Equity Ratio
0.180.180.300.110.270.32
Net Debt / EBITDA Ratio
0.780.781.160.390.910.99
Net Debt / FCF Ratio
1.431.431.480.616.343.70
Asset Turnover
0.800.800.770.810.800.78
Inventory Turnover
5.535.535.616.806.546.38
Quick Ratio
0.660.660.870.891.030.45
Current Ratio
1.051.051.321.141.310.77
Return on Equity (ROE)
13.59%13.59%24.45%18.78%11.01%9.78%
Return on Assets (ROA)
6.46%6.46%7.71%7.58%7.17%8.19%
Return on Invested Capital (ROIC)
12.02%11.51%12.22%14.48%11.09%11.83%
Return on Capital Employed (ROCE)
14.20%14.20%14.60%19.10%15.70%21.00%
Earnings Yield
14.31%14.38%26.11%14.12%7.95%6.02%
FCF Yield
14.00%14.06%23.97%14.76%3.21%5.22%
Dividend Yield
3.98%--4.24%4.67%4.26%
Payout Ratio
27.07%27.07%17.60%27.51%51.75%61.31%
Buyback Yield / Dilution
-0.03%-0.03%0.01%-0.61%1.61%
Total Shareholder Return
3.95%-0.03%0.01%4.24%5.28%5.87%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.